Latest APRE reports update at 2024-05-14: 2024-Q12023-Q42023-Q1
Aprea Therapeutics logo
Aprea Therapeutics APRE
$ 5.5 7.11%

Aprea Therapeutics Operating Expenses 2011-2024 | APRE

Annual Operating Expenses Aprea Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
16.1 M 113 M 37.4 M 52.8 M 29.5 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
113 M 16.1 M 49.8 M

Quarterly Operating Expenses Aprea Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
3.53 M - 3.84 M 3.9 M 4.62 M - 4.2 M 98.5 M 8.07 M - 9.43 M 10 M 10.2 M - 12.2 M 14.5 M 11.9 M - 7.22 M 5.94 M 4.41 M - 2.93 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
98.5 M 2.93 M 12.7 M